Studies assessing efficacy of rifaximin versus norfloxacin for SBP prophylaxis
| Study | Year | Design | Number of subjects | Country | Primary outcome |
|---|---|---|---|---|---|
| Mostafa et al14 | 2015 | Single-center randomized controlled trial | 70 | Egypt | Serum inflammatory markers |
| Shamseya and Madkour15 | 2015 | Prospective observational study | 86 | Egypt | SBP |
| Assem et al16 | 2016 | Multicenter randomized controlled trial | 334 | Egypt and Saudi Arabia | SBP |
| Elfert et al17 | 2016 | Single-center randomized controlled trial | 262 | Egypt | SBP |